{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:31:57Z","timestamp":1787020317667,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T00:00:00Z","timestamp":1577664000000},"content-version":"vor","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bacterial meningitis (BM) is a serious, life-threatening infectious disease of the central nervous system that often occurs in young children. The most common severe to moderate sequelae following BM are sensorineural hearing loss, neuromotor disabilities and mental retardation, while subtle sequelae include academic and behavioral disabilities. It is largely unknown whether these more subtle sequelae persist into adolescence and adulthood. Therefore, this study will investigate the very long-term effects of childhood BM in later life. Better understanding of long-term effects and early identification of adverse outcomes after BM are essential for more timely interventions. Additionally, certain single nucleotide polymorphisms (SNPs) are associated with disease severity and might predict adverse sequelae. These include SNPs in genes encoding for pathogen recognition and immune response upon infection. Accordingly, a secondary objective of this study is to investigate the role of genetic variation in BM and use any insights to predict short- and long-term outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In the Dutch 20|30 Postmeningitis study, adolescents and young adults (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009947) from two historical cohorts with a prior episode of BM during childhood will be enrolled into a cross-sectional follow-up investigation using mainly questionnaires that examine executive and behavioral functioning, health-related quality of life, subjective hearing, mood and sleeping disorders, academic performance, and economic self-sufficiency. The results will be compared to normative data by one-sample t-tests. Multivariable regression analysis will be used to assess for any associations with causative pathogens and severity of BM. Participants that complete the questionnaires will be approached to provide a swab for buccal DNA and subsequent sequencing analyses. Logistic regression models will be used to predict sequelae.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The unique follow-up duration of this cohort will enable us to gain insights into the possible very long-term adverse effects of childhood BM and how these might impact on quality of life. The investigation of host genetic factors will contribute to the development of prediction models which will serve as prognostic tools to identify children who are at high risk of adverse outcome after BM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      Dutch Trial Register\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.trialregister.nl\/trial\/6657\">NTR-6891<\/jats:ext-link>\n                      . Retrospectively registered 28 December 2017.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-019-1900-1","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T01:02:41Z","timestamp":1577667761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Study protocol: The Dutch 20|30 Postmeningitis study: a cross-sectional follow-up of two historical childhood bacterial meningitis cohorts on long-term outcomes"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1387-292X","authenticated-orcid":false,"given":"O.","family":"El Tahir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. C. J.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ouburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Morr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"van Furth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,30]]},"reference":[{"key":"1900_CR1","volume-title":"Bacterial meningitis in the Netherlands annual report","author":"L Spanjaard","year":"2017","unstructured":"Spanjaard L. Bacterial meningitis in the Netherlands annual report 2017. https:\/\/www.hpsc.ie\/az\/vaccinepreventable\/bacterialmeningitis\/publications\/bacterialmeningitisannualreports\/"},{"issue":"21","key":"1900_CR2","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1056\/NEJMoa1005384","volume":"364","author":"MC Thigpen","year":"2011","unstructured":"Thigpen MC, Whitney CG, Messonnier NE, Zell ER, Lynfield R, Hadler JL, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011;364(21):2016\u201325.","journal-title":"N Engl J Med"},{"issue":"3","key":"1900_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S1473-3099(15)00430-2","volume":"16","author":"MW Bijlsma","year":"2016","unstructured":"Bijlsma MW, Brouwer MC, Kasanmoentalib ES, Kloek AT, Lucas MJ, Tanck MW, et al. Community-acquired bacterial meningitis in adults in the Netherlands, 2006-14: a prospective cohort study. Lancet Infect Dis. 2016;16(3):339\u201347.","journal-title":"Lancet Infect Dis"},{"issue":"22","key":"1900_CR4","first-page":"1069","volume":"144","author":"MA Conyn-van Spaendonck","year":"2000","unstructured":"Conyn-van Spaendonck MA, Veldhuijzen IK, Suijkerbuijk AW, Hirasing RA. Significant decline of the number of invasive Haemophilus influenzae infections in the first 4 years after introduction of vaccination against H. influenzae type B in children. Ned Tijdschr Geneeskd. 2000;144(22):1069\u201373.","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"5","key":"1900_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/00006454-199305000-00008","volume":"12","author":"LJ Baraff","year":"1993","unstructured":"Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J. 1993;12(5):389\u201394.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"1900_CR6","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1093\/clinids\/21.6.1390","volume":"21","author":"RF Kornelisse","year":"1995","unstructured":"Kornelisse RF, Westerbeek CM, Spoor AB, van der Heijde B, Spanjaard L, Neijens HJ, et al. Pneumococcal meningitis in children: prognostic indicators and outcome. Clin Infect Dis. 1995;21(6):1390\u20137.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1900_CR7","first-page":"394","volume":"55","author":"AP Johnson","year":"2007","unstructured":"Johnson AP, Waight P, Andrews N, Pebody R, George RC, Miller E. Morbidity and mortality of pneumococcal meningitis and serotypes of causative strains prior to introduction of the 7-valent conjugant pneumococcal vaccine in England. J Inf Secur. 2007;55(5):394\u20139.","journal-title":"J Inf Secur"},{"issue":"7312","key":"1900_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/bmj.323.7312.533","volume":"323","author":"H Bedford","year":"2001","unstructured":"Bedford H, de Louvois J, Halket S, Peckham C, Hurley R, Harvey D. Meningitis in infancy in England and Wales: follow up at age 5 years. BMJ. 2001;323(7312):533\u20136.","journal-title":"BMJ"},{"issue":"2","key":"1900_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/adc.83.2.111","volume":"83","author":"K Grimwood","year":"2000","unstructured":"Grimwood K, Anderson P, Anderson V, Tan L, Nolan T. Twelve year outcomes following bacterial meningitis: further evidence for persisting effects. Arch Dis Child. 2000;83(2):111\u20136.","journal-title":"Arch Dis Child"},{"issue":"5","key":"1900_CR10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1542\/peds.95.5.646","volume":"95","author":"K Grimwood","year":"1995","unstructured":"Grimwood K, Anderson VA, Bond L, Catroppa C, Hore RL, Keir EH, et al. Adverse outcomes of bacterial meningitis in school-age survivors. Pediatrics. 1995;95(5):646\u201356.","journal-title":"Pediatrics"},{"issue":"6","key":"1900_CR11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s00431-002-0957-1","volume":"161","author":"S Berg","year":"2002","unstructured":"Berg S, Trollfors B, Hugosson S, Fernell E, Svensson E. Long-term follow-up of children with bacterial meningitis with emphasis on behavioural characteristics. Eur J Pediatr. 2002;161(6):330\u20136.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"1900_CR12","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1542\/peds.112.5.1049","volume":"112","author":"I Koomen","year":"2003","unstructured":"Koomen I, Grobbee DE, Roord JJ, Donders R, Jennekens-Schinkel A, van Furth AM. Hearing loss at school age in survivors of bacterial meningitis: assessment, incidence, and prediction. Pediatrics. 2003;112(5):1049\u201353.","journal-title":"Pediatrics"},{"issue":"2","key":"1900_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1017\/S1355617797001471","volume":"3","author":"V Anderson","year":"1997","unstructured":"Anderson V, Bond L, Catroppa C, Grimwood K, Keir E, Nolan T. Childhood bacterial meningitis: impact of age at illness and acute medical complications on long term outcome. J Int Neuropsychol Soc. 1997;3(2):147\u201358.","journal-title":"J Int Neuropsychol Soc"},{"issue":"5","key":"1900_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1136\/adc.88.5.395","volume":"88","author":"S Halket","year":"2003","unstructured":"Halket S, de Louvois J, Holt DE, Harvey D. Long term follow up after meningitis in infancy: behaviour of teenagers. Arch Dis Child. 2003;88(5):395\u20138.","journal-title":"Arch Dis Child"},{"issue":"6","key":"1900_CR15","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s11136-004-7706-z","volume":"14","author":"I Koomen","year":"2005","unstructured":"Koomen I, Raat H, Jennekens-Schinkel A, Grobbee DE, Roord JJ, van Furth M. Academic and behavioral limitations and health-related quality of life in school-age survivors of bacterial meningitis. Qual Life Res. 2005;14(6):1563\u201372.","journal-title":"Qual Life Res"},{"issue":"2","key":"1900_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0165-5876(97)00129-8","volume":"42","author":"S Hugosson","year":"1997","unstructured":"Hugosson S, Carlsson E, Borg E, Brorson LO, Langeroth G, Olcen P. Audiovestibular and neuropsychological outcome of adults who had recovered from childhood bacterial meningitis. Int J Pediatr Otorhinolaryngol. 1997;42(2):149\u201367.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"1","key":"1900_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/INF.0b013e3181ef25f7","volume":"30","author":"A Chandran","year":"2011","unstructured":"Chandran A, Herbert H, Misurski D, Santosham M. Long-term sequelae of childhood bacterial meningitis: an underappreciated problem. Pediatr Infect Dis J. 2011;30(1):3\u20136.","journal-title":"Pediatr Infect Dis J"},{"key":"1900_CR18","doi-asserted-by":"crossref","unstructured":"Clark LJGL, Audrey S, Hickman M, Trotter CL. The health, social and educational needs of children who have survived meningitis and septicaemia; the parents' perspective. BMC Public Health. 2013.","DOI":"10.1186\/1471-2458-13-954"},{"issue":"8","key":"1900_CR19","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00431-010-1390-5","volume":"170","author":"D Christie","year":"2011","unstructured":"Christie D, Viner RM, Knox K, Coen PG, Wang H, El Bashir H, et al. Long-term outcomes of pneumococcal meningitis in childhood and adolescence. Eur J Pediatr. 2011;170(8):997\u20131006.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"1900_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2174\/1871526515999150320155614","volume":"14","author":"F Dastouri","year":"2014","unstructured":"Dastouri F, Hosseini AM, Haworth E, Khandaker G, Rashid H, Booy R. Complications of serogroup B meningococcal disease in survivors: a review. Infect Disord Drug Targets. 2014;14(3):205\u201312.","journal-title":"Infect Disord Drug Targets"},{"issue":"3","key":"1900_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1651-2227.2008.01136.x","volume":"98","author":"R Legood","year":"2009","unstructured":"Legood R, Coen PG, Knox K, Viner RM, El Bashir H, Christie D, et al. Health related quality of life in survivors of pneumococcal meningitis. Acta Paediatr. 2009;98(3):543\u20137.","journal-title":"Acta Paediatr"},{"issue":"4","key":"1900_CR22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/cid\/ciq155","volume":"52","author":"MS Sanders","year":"2011","unstructured":"Sanders MS, van Well GT, Ouburg S, Lundberg PS, van Furth AM, Morre SA. Single nucleotide polymorphisms in TLR9 are highly associated with susceptibility to bacterial meningitis in children. Clin Infect Dis. 2011;52(4):475\u201380.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1900_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064252","volume":"8","author":"GT van Well","year":"2013","unstructured":"van Well GT, Sanders MS, Ouburg S, Kumar V, van Furth AM, Morre SA. Single nucleotide polymorphisms in pathogen recognition receptor genes are associated with susceptibility to meningococcal meningitis in a pediatric cohort. PLoS One. 2013;8(5):e64252.","journal-title":"PLoS One"},{"issue":"5","key":"1900_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/gene.2011.20","volume":"12","author":"MS Sanders","year":"2011","unstructured":"Sanders MS, van Well GT, Ouburg S, Morre SA, van Furth AM. Genetic variation of innate immune response genes in invasive pneumococcal and meningococcal disease applied to the pathogenesis of meningitis. Genes Immun. 2011;12(5):321\u201334.","journal-title":"Genes Immun"},{"issue":"3","key":"1900_CR25","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1651-2227.2008.01163.x","volume":"98","author":"J Faber","year":"2009","unstructured":"Faber J, Henninger N, Finn A, Zenz W, Zepp F, Knuf M. A toll-like receptor 4 variant is associated with fatal outcome in children with invasive meningococcal disease. Acta Paediatr. 2009;98(3):548\u201352.","journal-title":"Acta Paediatr"},{"issue":"2","key":"1900_CR26","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1128\/IAI.01110-09","volume":"78","author":"S Ribes","year":"2010","unstructured":"Ribes S, Ebert S, Regen T, Agarwal A, Tauber SC, Czesnik D, et al. Toll-like receptor stimulation enhances phagocytosis and intracellular killing of nonencapsulated and encapsulated Streptococcus pneumoniae by murine microglia. Infect Immun. 2010;78(2):865\u201371.","journal-title":"Infect Immun"},{"issue":"3","key":"1900_CR27","doi-asserted-by":"publisher","first-page":"e58707","DOI":"10.1371\/journal.pone.0058707","volume":"8","author":"RC de Jonge","year":"2013","unstructured":"de Jonge RC, Sanders MS, Terwee CB, Heymans MW, Gemke RJ, Koomen I, et al. Independent validation of an existing model enables prediction of hearing loss after childhood bacterial meningitis. PLoS One. 2013;8(3):e58707.","journal-title":"PLoS One"},{"key":"1900_CR28","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/1471-2334-13-340","volume":"13","author":"MS Sanders","year":"2013","unstructured":"Sanders MS, de Jonge RC, Terwee CB, Heymans MW, Koomen I, Ouburg S, et al. Addition of host genetic variants in a prediction rule for post meningitis hearing loss in childhood: a model updating study. BMC Infect Dis. 2013;13:340.","journal-title":"BMC Infect Dis"},{"key":"1900_CR29","unstructured":"RCJ de Jonge EdKea. Diagnostic value of the strengths difficulties questionnaire and prevalence of behavioral functioning of childhood bacterial meningitis survivors. Unpublished.)"},{"key":"1900_CR30","doi-asserted-by":"crossref","unstructured":"Thompson T, Lloyd A, Joseph A, Weiss M. The Weiss Functional Impairment Rating Scale-Parent Form for assessing ADHD: evaluating diagnostic accuracy and determining optimal thresholds using ROC analysis. Qual Life Res. 2017.","DOI":"10.1007\/s11136-017-1514-8"},{"key":"1900_CR31","volume-title":"The Patient Reported Outcomes Measurement Information System PROMIS developed and tested its first wave of adult self- reported health outcome item banks","author":"DRW Cella","year":"2005","unstructured":"Cella DRW, Stone A et al. The Patient Reported Outcomes Measurement Information System PROMIS developed and tested its first wave of adult self- reported health outcome item banks 2005-2008."},{"issue":"2","key":"1900_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1044\/2015_JSLHR-H-15-0156","volume":"59","author":"JM Boeschen Hospers","year":"2016","unstructured":"Boeschen Hospers JM, Smits N, Smits C, Stam M, Terwee CB, Kramer SE. Reevaluation of the Amsterdam Inventory for Auditory Disability and Handicap Using Item Response Theory. J Speech Lang Hear Res. 2016;59(2):373\u201383.","journal-title":"J Speech Lang Hear Res"},{"issue":"4","key":"1900_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3109\/14992020309101317","volume":"42","author":"AG Meijer","year":"2003","unstructured":"Meijer AG, Wit HP, TenVergert EM, Albers FW, Muller Kobold JE. Reliability and validity of the (modified) Amsterdam Inventory for Auditory Disability and Handicap. Int J Audiol. 2003;42(4):220\u20136.","journal-title":"Int J Audiol"},{"issue":"6","key":"1900_CR34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3109\/00206099509071921","volume":"34","author":"SE Kramer","year":"1995","unstructured":"Kramer SE, Kapteyn TS, Festen JM, Tobi H. Factors in subjective hearing disability. Audiology. 1995;34(6):311\u201320.","journal-title":"Audiology"},{"issue":"12","key":"1900_CR35","doi-asserted-by":"publisher","first-page":"e0166939","DOI":"10.1371\/journal.pone.0166939","volume":"11","author":"Kineret Sharfi","year":"2016","unstructured":"Sharfi K, Rosenblum S. Executive functions, Time Organization and Quality of Life among Adults with Learning Disabilities. PLoS One. 2016;10(12):e0166939. https:\/\/doi.org\/10.1371\/journal.pone.0166939.","journal-title":"PLOS ONE"},{"key":"1900_CR36","unstructured":"Rabin LA RRea. Self- and informant reports of executive function on the BRIEF-A in MCI and older adults with cognitive complaints."},{"issue":"7","key":"1900_CR37","doi-asserted-by":"publisher","first-page":"A550","DOI":"10.1016\/j.jval.2014.08.1791","volume":"17","author":"C Bouwmans","year":"2014","unstructured":"Bouwmans C, Krol M, Brouwer W, Severens JL, Koopmanschap MA, Hakkaart L. IMTA Productivity Cost Questionnaire (IPCQ). Value Health. 2014;17(7):A550.","journal-title":"Value Health"},{"issue":"6","key":"1900_CR38","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jval.2015.05.009","volume":"18","author":"C Bouwmans","year":"2015","unstructured":"Bouwmans C, Krol M, Severens H, Koopmanschap M, Brouwer W, Hakkaart-van RL. The iMTA Productivity Cost Questionnaire: A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses. Value Health. 2015;18(6):753\u20138.","journal-title":"Value Health"},{"issue":"6","key":"1900_CR39","first-page":"1733","volume":"23","author":"CB Terwee","year":"2014","unstructured":"Terwee CB, Roorda LD, de Vet HC, Dekker J, Westhovens R, van Leeuwen J, et al. Dutch-Flemish translation of 17 item banks from the patient-reported outcomes measurement information system (PROMIS). Qual Life Res. 2014;23(6):1733\u201341.","journal-title":"Qual Life Res"},{"issue":"4","key":"1900_CR40","doi-asserted-by":"publisher","first-page":"e0120017","DOI":"10.1371\/journal.pone.0120017","volume":"10","author":"L Pasanen","year":"2015","unstructured":"Pasanen L, Holmstrom L, Sillanpaa MJ. Bayesian LASSO, scale space and decision making in association genetics. PLoS One. 2015;10(4):e0120017.","journal-title":"PLoS One"},{"key":"1900_CR41","doi-asserted-by":"crossref","unstructured":"Seyednasrollah F, Makela J, Pitkanen N, Juonala M, Hutri-Kahonen, Lehtimaki T, et al. Prediction of Adulthood Obesity Using Genetic and Childhood Clinical Risk Factors in the Cardiovascular Risk in Youn Finns Study. Circ Cardiovasc Genet. 2017;10(3):e001554.","DOI":"10.1161\/CIRCGENETICS.116.001554"},{"key":"1900_CR42","doi-asserted-by":"crossref","unstructured":"Nuotio J, Pitkanen N, Magnussen CG, Busco MJ, Venalainen MS, Elo LL, et al. Prediction of Adult Dyslipidemia Using Genetic and Childhood Clinical Risk Factors: The Cardiovascular Risk in Youn Finns Study. Circ Cardiovasc Genet. 2017;10(3):e001604.","DOI":"10.1161\/CIRCGENETICS.116.001604"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1900-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-019-1900-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1900-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T09:56:33Z","timestamp":1665309393000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-019-1900-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1900"],"URL":"https:\/\/doi.org\/10.1186\/s12887-019-1900-1","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"22 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the VU University Medical Center Amsterdam on 3rd August 2017 under the corresponding number: 2017.292. Written informed consent was and will be obtained from all participants. The Medical Ethics Review Committee of VU University Medical Center is registered with the US Office for Human Research Protections (OHRP) as IRB00002991. The FWA number assigned to VU University Medical Center is FWA00017598.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study has received funding from GlaxoSmithKline Biologicals SA and has undergone peer review by the funding organization. All authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"519"}}